134 related articles for article (PubMed ID: 20846101)
1. What's new in Waldenström macroglobulinemia.
Gertz MA
Leuk Lymphoma; 2010 Oct; 51(10):1765-6. PubMed ID: 20846101
[No Abstract] [Full Text] [Related]
2. Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.
Peinert S; Seymour JF
Leuk Lymphoma; 2010 Oct; 51(10):1767-70. PubMed ID: 20919859
[No Abstract] [Full Text] [Related]
3. Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients.
Rourke M; Anderson KC; Ghobrial IM
Leuk Lymphoma; 2010 Oct; 51(10):1779-92. PubMed ID: 20795787
[TBL] [Abstract][Full Text] [Related]
4. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
Zinzani PL; Tani M; Alinari L; Stefoni V; Baccarani M
Leuk Res; 2003 May; 27(5):465-6. PubMed ID: 12620298
[No Abstract] [Full Text] [Related]
5. Fludarabine in Waldenstrom's macroglobulinemia.
Souchet-Compain L; Nguyen S; Choquet S; Leblond V
Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
[TBL] [Abstract][Full Text] [Related]
6. [Waldenstrom macroglobulinemia].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Mar; 93(14):547-52, 577. PubMed ID: 15125068
[No Abstract] [Full Text] [Related]
7. Waldenström's macroglobulinemia.
Desikan KR; Dhodapkar MV; Barlogie B
Curr Treat Options Oncol; 2000 Jun; 1(2):97-103. PubMed ID: 12057047
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Waldenström´s macroglobulinaemia in the year 2014].
Adam Z; Krejčí M; Pour L; Ševčíková E
Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine in Waldenstrom's macroglobulinemia.
Leblond V; Choquet S
Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
[TBL] [Abstract][Full Text] [Related]
10. Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
Owen RG
Expert Opin Pharmacother; 2001 Jun; 2(6):945-52. PubMed ID: 11585010
[TBL] [Abstract][Full Text] [Related]
11. 2-Chlorodeoxyadenosine treatment of lymphoma.
Saven A; Piro LD
Cancer Treat Res; 1996; 85():15-26. PubMed ID: 9043772
[No Abstract] [Full Text] [Related]
12. Waldenström's macroglobulinemia.
McKenna JA
Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
[TBL] [Abstract][Full Text] [Related]
13. Rituximab-based treatments in Waldenström's macroglobulinemia.
Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
[TBL] [Abstract][Full Text] [Related]
15. Guidelines on the management of Waldenström macroglobulinaemia.
Johnson SA; Birchall J; Luckie C; Oscier DG; Owen RG;
Br J Haematol; 2006 Mar; 132(6):683-97. PubMed ID: 16487169
[No Abstract] [Full Text] [Related]
16. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
Pilorge S; Park S; Dreyfus F; Bouscary D; Tamburini J
Leuk Lymphoma; 2010 Dec; 51(12):2288-90. PubMed ID: 20929331
[No Abstract] [Full Text] [Related]
18. Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
Johnson SA; Owen RG; Oscier DG; Leblond V; Levy V; Jaeger U; Seymour JF
Clin Lymphoma; 2005 Mar; 5(4):294-7. PubMed ID: 15794869
[TBL] [Abstract][Full Text] [Related]
19. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
Tallman MS; Hakimian D
Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
[No Abstract] [Full Text] [Related]
20. The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.
Le Garff-Tavernier M; Herbi L; de Romeuf C; Azar N; Roos-Weil D; Bonnemye P; Urbain R; Leblond V; Merle-Beral H; Vieillard V
Haematologica; 2015 Apr; 100(4):e147-51. PubMed ID: 25552707
[No Abstract] [Full Text] [Related]
[Next] [New Search]